Project Details
| Status | Active |
|---|---|
| Effective start/end date | 13/08/20 → 12/08/25 |
Keywords
- clinical trial
- phase 1 study
- treatment safety
- treatment efficacy
- solid tumours
Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of the Anti-OX40 Agonist Monoclonal Antibody BGB-A445 in Combination With the Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors
- Day, Daphne (Primary Chief Investigator (PCI))
Project: Research